HUTCHMED (China) Ltd cotiza a 13.68 USD y tiene una capitalización bursátil de $2.4B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. It provides Fruquintinib, a selective and potent oral inhibitor of vascular endothe…
| Periodo | 2027-03 | 2022-03 | 2021-07 | 2021-06 |
|---|---|---|---|---|
| Real | — | $-0.03 | $-0.40 | $-0.30 |
| Estimado | — | $-0.13 | $-0.07 | $-0.37 |
| Sorpresa | — | +76.9% | -471.4% | +18.9% |
| Métrica | HCM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 38.7% | 57.0% | -18.4% |
| Operating Margin | -7.1% | -38.6% | +31.5% |
| Net Margin | 83.3% | -33.6% | +116.9% |
| FCF Margin | -14.4% | -13.9% | -0.5% |
| ROE | 36.9% | -40.4% | +77.3% |
| ROA | 26.1% | -32.0% | +58.1% |
| Current Ratio | 4.96 | 2.84 | +2.12 |
| Debt / Equity | 0.08 | 0.28 | -0.20 |